DNA Delivery with Electroporation

The potential for DNA vaccines in the treatment and prevention of cancer has gained great momentum since initial findings almost 2 decades ago that revealed that genetically engineered DNA can elicit an immune response. The combination of adjuvants and an effective delivery method such as electroporation is overcoming past setbacks for naked plasmid DNA (pDNA) as a potential preventive or therapeutic approach to cancer in large animals and humans. Creative Biolabs is a world leader in the field of cancer vaccine development. With our extensive experience and advanced platform, we are therefore confident in offering the best development services for DNA vaccine delivery methods including electroporation (EP). We guarantee the finest results for our customers all over the world.

DNA - Creative Biolabs

How Does EP Work

To date, numerous delivery methods have been investigated to boost efficacy of non-viral gene therapies such as lipid-mediated entry into cells, jet injection, gene gun delivery, and sonoporation. Although the exact mechanism of cellular macromolecule entry is still under discussion, entry of small molecules such as anticancer therapeutics seems to occur by simple diffusion after the pulse, and larger molecules such as pDNA are thought to enter through a multistep mechanism involving the interaction of the DNA molecule with the destabilized membrane during the pulse and then its passage across the membrane. The cell membrane then reseals and the cellular machinery uses the DNA code to produce the desired antigen. Antigen-presenting cells then engulf the produced antigen and transport them to the lymph nodes where the antibodies or T cells are produced to eliminate the cancerous cells.

The Effectiveness of EP as A Delivery Method for DNA Vaccines

Numerous preclinical studies have examined the effectiveness of EP as a delivery method for DNA vaccines. EP appears to have a great impact on immunogenicity and efficacy by increasing antigen delivery up to a 1000-fold over naked DNA delivery alone. The effectiveness of the delivery method of EP has been shown to improve antitumor immune responses when used in a prime/boost strategy. Different procedures of DNA vaccine delivery, namely intradermal injection, gene gun delivery, and intramuscular injection alone or with EP, were compared in a murine transgenic model of mammary carcinoma overexpressing HER2/neu. In this study, intramuscular delivery followed by EP elicited better protection against HER2/neu spontaneous tumor development and induced an immune response.

Overall, EP has been shown to be an efficient method for enhancing the uptake and expression of DNA vaccine candidates, enabling the use of a lower dose of vaccine with similar or higher efficacy. Optimization of EP will also increase its acceptability as a delivery method by potentially reducing the associated pain with the procedure. The current of intradermal vaccination by EP impacts antigen expression, inflammation, and the induction of both humoral and cellular immunity. In general, the delivery of DNA vaccines via either intramuscular, intratumoral, or intradermal EP has been proven to enhance antigen-specific antibody and cellular immunity compared to delivery to tissue alone.

Creative Biolabs is a leader in the field of vaccine development and has focused on the cancer vaccines for years. We have experienced experts and advanced platforms that are able to provide excellent services. If you are interested in our services, please contact us for more details.

Our services are for research use only. We do not provide services directly to individuals.

Online Inquiry

*E-mail Address:
*Products or Services Interested:
Project Description:
*Verification Code:
Verification code
Click image to refresh the verification code.


45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-466-5530
Fax: 1-631-207-8356
Email: Europe
Heidenkampsweg 58, 20097 Hamburg, Germany
Tel: 44-207-097-1828 Email:

Follow us on

facebook   twitter   linked   blog

Shopping Basket